@misc{indiciae3068b151c5e0,
  title = {Activation of the myeloid checkpoint inhibitor LILRB3 (ILT5) elicits profound immununomodulation},
  author = {Yeboah, M. and Papagregoriou, C. and Jones, D. C. and Chan, H. T. C. and Hu, G. and McPartlan, J. S. and Schiott, T. and Mattson, U. and Mockridge, C. I. and Tornberg, U.-C. and Hambe, B. and Ljungars, A. and Mattsson, M. and Tews, I. and Thirdborough, S. M. and Trowsdale, J. and Frendeus, B. and Chen, J. and Cragg, M. S. and Roghanian, A.},
  year = {2020},
  doi = {10.1101/2020.06.04.135400},
  url = {https://www.biorxiv.org/content/10.1101/2020.06.04.135400v1},
  note = {Source identifier: 10.1101/2020.06.04.135400}
}